Opus Genetics Inc (IRD)
1.065
-0.02
(-2.29%)
USD |
NASDAQ |
Nov 14, 16:00
1.11
+0.04
(+4.23%)
After-Hours: 19:56
Opus Genetics Shareholders Equity (Quarterly): 40.64M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 40.64M |
| March 31, 2024 | 46.06M |
| December 31, 2023 | 49.91M |
| September 30, 2023 | 50.28M |
| June 30, 2023 | 37.70M |
| March 31, 2023 | 41.25M |
| December 31, 2022 | 46.24M |
| September 30, 2022 | 11.88M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.60M |
| March 31, 2022 | 17.27M |
| December 31, 2021 | 22.22M |
| September 30, 2021 | 20.57M |
| June 30, 2021 | 22.55M |
| March 31, 2021 | 9.816M |
| December 31, 2020 | -13.47M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-13.47M
Minimum
Dec 2020
50.28M
Maximum
Sep 2023
27.83M
Average
22.55M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Baxter International Inc | 7.643B |
| Syros Pharmaceuticals Inc | -11.12M |
| Elanco Animal Health Inc | 6.523B |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 44.83M |
| Total Liabilities (Quarterly) | 4.198M |
| Current Ratio | 10.68 |